FALLOPIAN TUBE MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR

Clinical trials for FALLOPIAN TUBE MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR explained in plain language.

Never miss a new study

Get alerted when new FALLOPIAN TUBE MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR trials appear

Sign up with your email to follow new studies for FALLOPIAN TUBE MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat ovarian cancers in early trial

Disease control Ongoing

This early-stage study is testing a new two-drug combination for women with ovarian cancer that has returned after previous treatment. The main goal is to find the safest and most effective dose of an experimental pill (peposertib) when given with a standard chemotherapy drug. Re…

Matched conditions: FALLOPIAN TUBE MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

FALLOPIAN TUBE MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR

Get alerted when new FALLOPIAN TUBE MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR trials appear

New hope for Tough-to-Treat ovarian cancers in early trial